These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2537578

  • 21. Alterations of Na,K-ATPase isoenzymes in the rat diabetic neuropathy: protective effect of dietary supplementation with n-3 fatty acids.
    Gerbi A, Maixent JM, Barbey O, Jamme I, Pierlovisi M, Coste T, Pieroni G, Nouvelot A, Vague P, Raccah D.
    J Neurochem; 1998 Aug; 71(2):732-40. PubMed ID: 9681464
    [Abstract] [Full Text] [Related]

  • 22. Nerve Na+-K+-ATPase, conduction, and myo-inositol in the insulin-deficient BB rat.
    Greene DA, Yagihashi S, Lattimer SA, Sima AA.
    Am J Physiol; 1984 Oct; 247(4 Pt 1):E534-9. PubMed ID: 6093549
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney.
    Raccah D, Lamotte-Jannot MF, Issautier T, Vague P.
    Diabete Metab; 1994 Oct; 20(3):271-4. PubMed ID: 8001715
    [Abstract] [Full Text] [Related]

  • 26. Reduced Na+/K+ adenosine triphosphatase activity and motor nerve conduction velocity in L-fucose-fed rats is reversible after dietary normalization.
    Yorek MA, Wiese TJ, Davidson EP, Dunlap JA, Conner CE.
    Metabolism; 1996 Feb; 45(2):229-34. PubMed ID: 8596495
    [Abstract] [Full Text] [Related]

  • 27. Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.
    Greene DA.
    Drugs; 1986 Feb; 32 Suppl 2():6-14. PubMed ID: 3024950
    [Abstract] [Full Text] [Related]

  • 28. Sustained recovery of Na(+)-K(+)-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitors of PKC.
    Hermenegildo C, Felipo V, Miñana MD, Romero FJ, Grisolía S.
    Diabetes; 1993 Feb; 42(2):257-62. PubMed ID: 7678826
    [Abstract] [Full Text] [Related]

  • 29. Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine.
    Ido Y, McHowat J, Chang KC, Arrigoni-Martelli E, Orfalian Z, Kilo C, Corr PB, Williamson JR.
    Diabetes; 1994 Dec; 43(12):1469-77. PubMed ID: 7958501
    [Abstract] [Full Text] [Related]

  • 30. Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters.
    Djemli-Shipkolye A, Coste T, Raccah D, Vague P, Pieroni G, Gerbi A.
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):297-304. PubMed ID: 11355004
    [Abstract] [Full Text] [Related]

  • 31. Effects of hypoxia and severity of diabetes on Na,K-ATPase activity and arachidonoyl-containing glycerophospholipid molecular species in nerve from streptozotocin diabetic rats.
    Doss DJ, Kuruvilla R, Bianchi R, Peterson RG, Eichberg J.
    J Peripher Nerv Syst; 1997 Mar; 2(2):155-63. PubMed ID: 10959229
    [Abstract] [Full Text] [Related]

  • 32. Protein kinase C effects on nerve function, perfusion, Na(+), K(+)-ATPase activity and glutathione content in diabetic rats.
    Cameron NE, Cotter MA, Jack AM, Basso MD, Hohman TC.
    Diabetologia; 1999 Sep; 42(9):1120-30. PubMed ID: 10447525
    [Abstract] [Full Text] [Related]

  • 33. Effect of gangliosides on diacylglycerol content and molecular species in nerve from diabetic rats.
    Bianchi R, Zhu X, Fiori MG, Eichberg J.
    Eur J Pharmacol; 1993 Aug 03; 239(1-3):55-61. PubMed ID: 8223914
    [Abstract] [Full Text] [Related]

  • 34. Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved.
    Martínez-Blasco A, Bosch-Morell F, Trenor C, Romero FJ.
    Biofactors; 1998 Aug 03; 8(1-2):41-3. PubMed ID: 9699007
    [Abstract] [Full Text] [Related]

  • 35. cAMP regulates nitric oxide production and ouabain sensitive Na+, K+-ATPase activity in SH-SY5Y human neuroblastoma cells.
    Inada H, Shindo H, Tawata M, Onaya T.
    Diabetologia; 1998 Dec 03; 41(12):1451-8. PubMed ID: 9867212
    [Abstract] [Full Text] [Related]

  • 36. Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes.
    Naka K, Sasaki H, Kishi Y, Furuta M, Sanke T, Nanjo K, Mukoyama M.
    Diabetes Res Clin Pract; 1995 Dec 03; 30(3):153-62. PubMed ID: 8861454
    [Abstract] [Full Text] [Related]

  • 37. Impaired rodent vagal nerve sodium-potassium-ATPase activity in streptozotocin diabetes.
    Nowak TV, Castelaz C, Ramaswamy K, Weisbruch JP.
    J Lab Clin Med; 1995 Feb 03; 125(2):182-6. PubMed ID: 7844468
    [Abstract] [Full Text] [Related]

  • 38. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
    Pop-Busui R, Marinescu V, Van Huysen C, Li F, Sullivan K, Greene DA, Larkin D, Stevens MJ.
    Diabetes; 2002 Aug 03; 51(8):2619-28. PubMed ID: 12145179
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.